A genetic schizophrenia-susceptibility region located between the ANKK1 and DRD2 genes
Caroline Dubertret(Sulzer (United Kingdom)), Laurent Gouya(Hôpital Louis-Mourier), Philip Gorwood(Inserm), J. Adès(Centre National de la Recherche Scientifique), Pierre-Marie Martin(Inserm), Nicolás Ramoz(Inserm), Claire Bardel(Centre Hospitalier Universitaire de Grenoble), Jean‐Charles Deybach(Assistance Publique – Hôpitaux de Paris)
Progress in Neuro-Psychopharmacology and Biological Psychiatry
February 9, 2010
Cited by 49
Related Papers
How mental health care should change as a consequence of the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.9k
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
|Nature Reviews Drug Discovery|2012|1.3k
The consequences of the COVID-19 pandemic on mental health and implications for clinical practice
|European Psychiatry|2020|1.2k